Norman Schwartz - Nov 1, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Stock symbol
BIO
Transactions as of
Nov 1, 2023
Transactions value $
-$4,817,860
Form type
4
Date filed
11/2/2023, 11:28 AM
Previous filing
Sep 6, 2023
Next filing
Dec 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad B Common Stock Options Exercise $4.19M +35K +10.14% $119.80 380K Nov 1, 2023 Direct
transaction BIO Bio-Rad B Common Stock Tax liability -$7M -25.6K -6.74% $273.00 355K Nov 1, 2023 Direct
transaction BIO Bio-Rad B Common Stock Options Exercise $2.23M +16K +4.51% $139.56 371K Nov 1, 2023 Direct
transaction BIO Bio-Rad B Common Stock Tax liability -$3.35M -12.3K -3.31% $273.00 358K Nov 1, 2023 Direct
transaction BIO Bio-Rad B Common Stock Options Exercise $2.39M +15K +4.19% $159.32 373K Nov 1, 2023 Direct
transaction BIO Bio-Rad B Common Stock Tax liability -$3.28M -12K -3.22% $273.00 361K Nov 1, 2023 Direct
holding BIO Bio-Rad B Common Stock 12.9K Nov 1, 2023 By Spouse F1
holding BIO Bio-Rad B Common Stock 4.06M Nov 1, 2023 By Blue Raven Partners, L.P. F2
holding BIO Bio-Rad A Common Stock 433K Nov 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -35K -100% $0.00* 0 Nov 1, 2023 Bio-Rad B Common Stock 35K $119.80 Direct F3
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -16K -100% $0.00* 0 Nov 1, 2023 Bio-Rad B Common Stock 16K $139.56 Direct F4
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -15K -100% $0.00* 0 Nov 1, 2023 Bio-Rad B Common Stock 15K $159.32 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these shares.
F2 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 The option, representing a right to purchase a total of 35,000 shares, became exercisable in five equal annual installments beginning on September 10, 2015, which was the first anniversary of the date on which the option was granted.
F4 The option, representing a right to purchase a total of 16,000 shares, became exercisable in five equal annual installments beginning on September 11, 2016, which was the first anniversary of the date on which the option was granted.
F5 The option, representing a right to purchase a total of 15,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.